cml-info.com
CML-Info - CML-Studies
http://www.cml-info.com/de/healthcare-professionals/cml-studies.html
Kompetenznetz für akute und chronische Leukämien. Laufende Therapiestudien für chronische myeloische Leukämie. Genaue Einschlusskriterien sind den Studienprotokollen im Internet zu entnehmen bzw. bei den Studienzentren zu erfragen). Weitere Informationen finden Sie im Kompetenznetz für akute und chronische Leukämie.
cml-info.com
CML-Info - CML News
http://www.cml-info.com/de/healthcare-professionals/news-events.html
Most CML patients who have a suboptimal response to imatinib have low OCT-1 Activity. Higher doses of imatinib may overcome the negative impact of low OCT-1 Activity. Blood 2007 Aug 30; [Epub ahead of print]. FTY720, a new alternative for treating blast crisis chronic myelogenous leukemia and Philadelphia chromosome-positive acute lymphocytic leukemia. J Clin Invest. 2007 Aug 23; [Epub ahead of print]. How I treat chronic myeloid leukemia in the imatinib era.
cml-info.com
CML-Info - Central European Leukemia Study Group
http://www.cml-info.com/de.html
Aktuelle Infos and Services für CML-Patienten and Betroffene. weiter. Möchten Sie wissen, an wen Sie sich wenden können? Hier finden Sie die wichtigsten Kontaktdaten von CML-Experten in Ihrer Nähe. Infos rund um CML. Möchten Sie mehr über die chronische myeloische Leukämie(CML) wissen? Hier finden Sie Infos über die Erkrankung, Infos zu Behandlungsmöglichkeiten und eine Reihe weiterer wichtiger Informationen. Infos and Services for Healthcare Professionals. CML Informations and Services.
cml-info.com
CML-Info - Key Publications
http://www.cml-info.com/de/healthcare-professionals/key-publications.html
Nilotinib as frontline and second-line therapy in chronic myeloid leukemia: Open questions. Valent P, Gastl G, Geissler K, Greil R, Hantschel O, Lang A, Linkesch W, Lion T, Petzer AL, Pittermann E, Pleyer L, Thaler J, Wolf D. Crit Rev Oncol Hematol. 2011 Sep 6. [Epub ahead of print] PMID: 21903413. First annual report of the Austrian CML registry. Petzer AL, Wolf D, Fong D, Lion T, Dyagil I, Masliak Z, Bogdanovic A, Griskevicius L, Lejniece S, Goranov S, Gercheva L, Stojanovic A, Peytchev D, Tzvetkov N, ...
patient-registry.com
Case Studies - patient-registry.com
http://patient-registry.com/en/beispiele.html
Skip to main navigation. Skip to section navigation. The first clinical patient registry we developed has been online since 2002 and is now used in more than ten countries. From the very beginning, we focused on online technologies which build a bridge between decentralized data collection and a centralized database. Other patient registries were developed in the years that followed. The features and underlying technologies have been developed and updated on a continuous basis. The Austrian Myeloma Regis...
celsg.com
CML-Info - CML News
http://www.celsg.com/de/healthcare-professionals/news-events.html
Most CML patients who have a suboptimal response to imatinib have low OCT-1 Activity. Higher doses of imatinib may overcome the negative impact of low OCT-1 Activity. Blood 2007 Aug 30; [Epub ahead of print]. FTY720, a new alternative for treating blast crisis chronic myelogenous leukemia and Philadelphia chromosome-positive acute lymphocytic leukemia. J Clin Invest. 2007 Aug 23; [Epub ahead of print]. How I treat chronic myeloid leukemia in the imatinib era.
celsg.com
CML-Info - CML-Studies
http://www.celsg.com/de/healthcare-professionals/cml-studies.html
Kompetenznetz für akute und chronische Leukämien. Laufende Therapiestudien für chronische myeloische Leukämie. Genaue Einschlusskriterien sind den Studienprotokollen im Internet zu entnehmen bzw. bei den Studienzentren zu erfragen). Weitere Informationen finden Sie im Kompetenznetz für akute und chronische Leukämie.
cml-info.com
CML-Info - About CML
http://www.cml-info.com/de/healthcare-professionals/about-cml.html
Chronic myeloid leukaemia (CML) is a myeloproliferative disorder (MPD) affecting 1 to 2 people per 100,000 annually. MPDs arise from genetic defects in haematopoietic stem cells, and are associated with an increased production of mature and immature blood cells, which affects one or all cell lineages. Shared Features of MPDs. Progression through clinical stages of increasing aggressiveness. Polycythaemia vera (PV): A malignancy that affects erythrocytes. Epidemiology and Aetiology of CML. In adults, CML ...